Friday, April 1, 2022

Armata Pharmaceuticals Gets $26.9M In Private Placement

Marina Del Rey-based Armata Pharmaceuticals, a publicly held biotech company focused on bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, said on Thursday that it has raised $26.9M in the second tranche a private placement. The company said the funding came from Innoviva Strategic Opportunities LLC, a wholly-owned subsidiary of Innoviva. The investment brings its total raised from Innoviva to $45M, including an earlier investment in February worth $18.1M.